Chitosan-based delivery systems for protein therapeutics and antigens.
Therapeutic peptides/proteins and protein-based antigens are chemically and structurally labile compounds, which are almost exclusively administered by parenteral injections. Recently, non-invasive mucosal routes have attracted interest for administration of these biotherapeutics. Chitosan-based delivery systems enhance the absorption and/or cellular uptake of peptides/proteins across mucosal sites and have immunoadjuvant properties. Chitosan is a mucoadhesive polysaccharide capable of opening the tight junctions between epithelial cells and it has functional groups for chemical modifications, which has resulted in a large variety of chitosan derivatives with tunable properties for the aimed applications. This review provides an overview of chitosan-based polymers for preparation of both therapeutic peptides/protein and antigen formulations. The physicochemical properties of these carrier systems as well as their applications in protein and antigen delivery through parenteral and mucosal (particularly nasal and pulmonary) administrations are summarized and discussed.
Amidi
Maryam
M
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands. M.Amidi@uu.nl
Mastrobattista
Enrico
E
Jiskoot
Wim
W
Hennink
Wim E
WE
D000818:Animals; D000941:Antigens / Q000008:administration & dosage* / Q000737:chemistry; D048271:Chitosan / Q000008:administration & dosage* / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D009297:Nasal Mucosa / Q000187:drug effects / Q000276:immunology; D011506:Proteins / Q000008:administration & dosage* / Q000737:chemistry; D020545:Respiratory Mucosa / Q000187:drug effects / Q000276:immunology / Q000378:metabolism
D000941:Antigens; D011506:Proteins; D048271:Chitosan